@ARTICLE{
author={Howard James F Jr,Bril Vera,Tuan Vu,Karam Chafic,Peric Stojan Z,De Bleecker Jan L,Murai Hiroyuki,Pasnoor Mamatha,Sacca Francesco,Meisel Andreas,Guglietta Antonio,T'joen Caroline,Utsugisawa Kimiaki,Verschuuren Jan,Mantegazza Renato},
year={2022},
title={Efficacy, Safety, and Tolerability of Efgartigimod in Acetylcholine Receptor Autoantibody Seronegative Patients with Generalized Myasthenia Gravis: Integrated Interim Analysis of the Adapt and Adapt plus Studies},
journal={MUSCLE & NERVE},
volume={65},
number={},
pages={S13-S14},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Howard James F Jr,Bril Vera,Tuan Vu,Karam Chafic,Peric Stojan Z,De Bleecker Jan L,Murai Hiroyuki,Meisel Andreas,Beydoun Said,Pasnoor Mamatha,Guglietta Antonio,T'joen Caroline,Utsugisawa Kimiaki,Verschuuren Jan,Mantegazza Renato},
year={2022},
title={Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Interim Results of the Adapt plus Study},
journal={MUSCLE & NERVE},
volume={65},
number={},
pages={S9-S10},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Howard James,Bril Vera,Vu Tuan,Karam Chafic,Peric Stojan Z,Murai Hiroyuki,Guglietta Antonio,Ulrichts Peter,Vangeneugden Tony,Utsugisawa Kimiaki,Verschuuren Jan JGM,Mantegazza Renato},
year={2021},
title={Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study},
journal={NEUROLOGY},
volume={96},
number={15},
pages={-},
document_type={Meeting Abstract},
}